Evidence map›Paper›PMID 25346848›Full record

ArticleBiomaterials science2014

Survival, Differentiation, and Migration of High-Purity Mouse Embryonic Stem Cell-derived Progenitor Motor Neurons in Fibrin Scaffolds after Sub-Acute Spinal Cord Injury.

D A McCreedy, T S Wilems, H Xu, J C Butts, C R Brown, A W Smith, S E Sakiyama-Elbert

Abstract read
In one paragraph

Article in Biomaterials science, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Regenerative Therapies for Spinal Cord Injury.Tissue engineering. Part B, Reviews · 2019
    Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

D A McCreedyDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO 63112, USA.
T S WilemsDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO 63112, USA.
H XuDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO 63112, USA.
J C ButtsDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO 63112, USA.
C R BrownDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO 63112, USA.
A W SmithDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO 63112, USA.
S E Sakiyama-ElbertDepartment of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO 63112, USA.
Washington University in St. Louis · US

Funding

FIBRIN BASED SCAFFOLDS FOR SPINAL CORD INJURYR01NS051454 · NINDS · WASHINGTON UNIVERSITY · PI SAKIYAMA-ELBERT, SHELLY ELESE · 2005 to 2013
$2.4M
NINDS NIH HHS R01 NS051454
6 · The paper itself

Abstract

Embryonic stem (ES) cells can be differentiated into many neural cell types that hold great potential as cell replacement therapies following spinal cord injury (SCI). Coupling stem cell transplantation with biomaterial scaffolds can produce a unified combination therapy with several potential advantages including enhanced cell survival, greater transplant retention, reduced scarring, and improved integration at the transplant/host interface. Undesired cell types, however, are commonly present in ES-cell derived cultures due to the limited efficiency of most ES cell induction protocols. Heterogeneous cell populations can confound the interaction between the biomaterial and specific neural populations leading to undesired outcomes. In particular, biomaterials scaffolds may enhance tumor formation by promoting survival and proliferation of undifferentiated ES cells that can persist after induction. Methods for purification of specific ES cell-derived neural populations are necessary to recognize the full potential of combination therapies involving biomaterials and ES cell-derived neural populations. We previously developed a method for enriching ES cell-derived progenitor motor neurons (pMNs) induced from mouse ES cells via antibiotic selection and showed that the enriched cell populations are depleted of pluripotent stem cells. In this study, we demonstrate the survival and differentiation of enriched pMNs within three dimensional (3D) fibrin scaffolds

Identifiers

PMID25346848
PMCPMC4206060
OpenAlexW2010121754

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.